Federal Circuit Rules Against The Medicines Company In Angiomax (bivalirudin) Patent Litigation

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) announced the U.S. Court of Appeals for the Federal Circuit Court has ruled against the Company in its Angiomax® (bivalirudin) patent litigation with Hospira, Inc.

Help employers find you! Check out all the jobs and post your resume.